Navigating regulatory challenges with Viralgen’s head of regulatory affairs María Orío
Gene therapy holds the promise to transform how we treat a range of genetic diseases, but significant barriers still stand in the way of widespread adoption. From complex manufacturing processes to regulatory challenges, the path to developing effective therapies is far from straightforward. In this podcast, industry experts delve into these critical hurdles, discussing innovative strategies to overcome them and accelerate the development of life-saving treatments. Tune in to learn how the field is evolving and what’s being done to bring these breakthrough therapies to patients in need.